BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 23639628)

  • 1. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
    Cummings D; Cruise M; Lopez R; Roggenbuck D; Jairath V; Wang Y; Shen B; Rieder F
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1251-1259. PubMed ID: 30411391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.
    Reshef L; Kovacs A; Ofer A; Yahav L; Maharshak N; Keren N; Konikoff FM; Tulchinsky H; Gophna U; Dotan I
    Gastroenterology; 2015 Sep; 149(3):718-27. PubMed ID: 26026389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
    Coukos JA; Howard LA; Weinberg JM; Becker JM; Stucchi AF; Farraye FA
    Dig Dis Sci; 2012 Jun; 57(6):1544-53. PubMed ID: 22311367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
    Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis.
    Ettorre GM; Pescatori M; Panis Y; Nemeth J; Crescenzi A; Valleur P
    Dis Colon Rectum; 2000 Dec; 43(12):1743-8. PubMed ID: 11156461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal pouch complications in patients who underwent restorative proctocolectomy for ulcerative colitis and familial adenomatous polyposis in 1985-2008.
    Burdyński R; Banasiewicz T; Marciniak R; Biczysko M; Szmeja J; Paszkowski J; Grochowalski M; Maik J; Majewski P; Krokowicz P; Drews M
    Pol Przegl Chir; 2011 Mar; 83(3):161-70. PubMed ID: 22166319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis.
    Murrell ZA; Melmed GY; Ippoliti A; Vasiliauskas EA; Dubinsky M; Targan SR; Fleshner PR
    Dis Colon Rectum; 2009 May; 52(5):872-8. PubMed ID: 19502850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
    Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
    Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis.
    Lu H; Lian L; Navaneethan U; Shen B
    Inflamm Bowel Dis; 2010 Oct; 16(10):1678-84. PubMed ID: 20186934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch.
    Pavlidis P; Forbes A; Bogdanos DP
    J Crohns Colitis; 2013 Dec; 7(11):e602-3. PubMed ID: 23845232
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical approach to diseases of ileal pouch-anal anastomosis.
    Shen B; Fazio VW; Remzi FH; Lashner BA
    Am J Gastroenterol; 2005 Dec; 100(12):2796-807. PubMed ID: 16393238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Huang Y; Dalal S; Antonopoulos D; Hubert N; Raffals LH; Dolan K; Weber C; Messer JS; Jabri B; Bendelac A; Eren AM; Rubin DT; Sogin M; Chang EB
    Inflamm Bowel Dis; 2017 Mar; 23(3):366-378. PubMed ID: 28221248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure.
    Syal G; Shemtov R; Bonthala N; Vasiliauskas EA; Feldman EJ; Zaghiyan K; Ha CY; McGovern DPB; Targan SR; Melmed GY; Fleshner PR
    J Crohns Colitis; 2021 Jun; 15(6):960-968. PubMed ID: 33300546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review.
    Hoda KM; Collins JF; Knigge KL; Deveney KE
    Dis Colon Rectum; 2008 May; 51(5):554-60. PubMed ID: 18266037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Matalon S; Elad H; Brazowski E; Santo E; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Mar; 21(3):589-95. PubMed ID: 25659085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
    Papp M; Sipeki N; Tornai T; Altorjay I; Norman GL; Shums Z; Roggenbuck D; Fechner K; Stöcker W; Antal-Szalmas P; Veres G; Lakatos PL
    J Crohns Colitis; 2015 Aug; 9(8):659-68. PubMed ID: 25968583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.